A Study to Compare the Efficacy and Safety of Fluticasone Furoate (FF) 100 mcg Once Daily with Fluticasone Propionate (FP) 250 mcg Twice Daily (BD) and FP 100 mcg BD in Well-controlled Asthmatic Japanese Subjects

Trial Identifier: 201135
Sponsor: GlaxoSmithKline
NCTID:: NCT02094937
Start Date: March 2014
Primary Completion Date: August 2015
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Version
Japanese Version

Trial Locations

Country Location
Japan Aomori, Japan, 036-8545
Japan Fukuoka, Japan, 811-1394
Japan Fukuoka, Japan, 832-0059
Japan Fukuoka, Japan, 802-0052
Japan Fukuoka, Japan, 816-0813
Japan Gifu, Japan, 509-6134
Japan Hiroshima, Japan, 732-0052
Japan Hyogo, Japan, 672-8064
Japan Ibaraki, Japan, 319-1113
Japan Ibaraki, Japan, 302-0022
Japan Kagawa, Japan, 760-0018
Japan Kagawa, Japan, 762-0031
Japan Kagawa, Japan, 761-8073
Japan Kagawa, Japan, 760-8538
Japan Kanagawa, Japan, 239-0821
Japan Kanagawa, Japan, 252-0143
Japan Kochi, Japan, 780-0901
Japan Kyoto, Japan, 612-0026
Japan Mie, Japan, 514-1101
Japan Mie, Japan, 515-8544
Japan Oita, Japan, 870-0921
Japan Osaka, Japan, 560-0005
Japan Saitama, Japan, 343-0808
Japan Tokyo, Japan, 191-0031
Japan Tokyo, Japan, 187-0002
Japan Tokyo, Japan, 171-0014
Japan Tokyo, Japan, 145-0063
Japan Tokyo, Japan, 104-8560
Japan Tokyo, Japan, 103-0027
Japan Tokyo, Japan, 140-0013
Japan Tokyo, Japan, 204-8522
Japan Tokyo, Japan, 140-0011
Japan Tokyo, Japan, 190-0014